OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology [Yahoo! Finance]
OmniAb, Inc. (OABI)
Company Research
Source: Yahoo! Finance
EMERYVILLE, Calif., June 03, 2024 BUSINESS WIRE OmniAb, Inc. (NASDAQ: OABI) today announced the publication of a peer-reviewed paper titled "Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies. sdAbs are produced naturally by camelids and have gained popularity as small, robust and highly modular building blocks for antibody discovery. While most other vertebrates use the standard heterodimeric IgG structure due to the pairing of heavy and light chains and do not produce sdAb format immunoglobulins, OmniAb's scientific team led this study to investigate if chickens can support an immune repertoire based upon a heavy chain-only scaffold. "Our team's published data provided the foundational work supporting the feasibility of the Company's next-generation transgenic chicken Omni dAb that produ
Show less
Read more
Impact Snapshot
Event Time:
OABI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OABI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OABI alerts
High impacting OmniAb, Inc. news events
Weekly update
A roundup of the hottest topics
OABI
News
- OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyBusiness Wire
- Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 34%? [Yahoo! Finance]Yahoo! Finance
- OmniAb to Participate in the Jefferies Global Healthcare ConferenceBusiness Wire
- OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitBusiness Wire
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
OABI
Earnings
- 5/9/24 - Miss
OABI
Sec Filings
- 5/28/24 - Form 4
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- OABI's page on the SEC website